Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FPR2 | P25090 | 1/20 | 0.41 |
| ▸ | ACE | P12821 | 4/20 | 0.41 |
| ▸ | MME | P08473 | 1/20 | 0.41 |
| ▸ | CPA1 | P15085 | 1/20 | 0.41 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.41 |
| ▸ | CTSL | P07711 | 1/20 | 0.39 |
| ▸ | TAS2R14 | Q9NYV8 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.39 |
| ▸ | KIFC1 | Q9BW19 | 2/20 | 0.39 |
| ▸ | TACR1 | P25103 | 6/20 | 0.38 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.37 |
| ▸ | ITGAV | P06756 | 1/20 | 0.37 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25356612 | 0.92 | ACE (0.46) | FPR2ACEMMECPA1ACE2 | |
| SCHEMBL25356607 | 0.92 | ACE (0.46) | FPR2ACEMMECPA1ACE2 | |
| SCHEMBL25356585 | 0.86 | XIAP (0.44) | FPR2ACEMMECPA1ACE2 | |
| SCHEMBL25356589 | 0.86 | XIAP (0.44) | FPR2ACEMMECPA1ACE2 | |
| SCHEMBL29855163 | 0.81 | HTR2A (0.55) | FPR2CTSL | |
| SCHEMBL22444621 | 0.81 | HTR2A (0.55) | FPR2CTSL | |
| SCHEMBL22444715 | 0.80 | FPR2 (0.57) | FPR2ACEMMECPA1ACE2 | |
| SCHEMBL21952322 | 0.80 | FPR2 (0.57) | FPR2ACEMMECPA1ACE2 | |
| SCHEMBL25358943 | 0.80 | CYP11B1 (0.43) | FPR2ACEMMECPA1ACE2 | |
| SCHEMBL25358945 | 0.80 | CYP11B1 (0.43) | FPR2ACEMMECPA1ACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230257343-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2023-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230257343-A1 | NOVEL AMINO ACID DERIVATIVES | DNPEP, BCAT1, ANPEP | FPR2 1354/4885ACE 458/4885MME 220/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.